News >

Cell-Free DNA Shows Potential in Identifying Transformed Castration-Resistant Neuroendocrine Prostate Cancer

Brittany Cote
Published: Friday, Mar 20, 2020

Himisha Beltran, MD, an associate professor of medicine at Lank Center for Genitourinary Oncology and Division of Molecular and Cellular Oncology at the Dana-Farber Cancer Institute and Harvard Medical School

Himisha Beltran, MD

Cell-free DNA (cfDNA) can potentially be utilized as an approach to identify patients with prostate adenocarcinoma that has transformed to castration-resistant neuroendocrine prostate cancer (CRPC-NE), according to results of a study that have been published in the Journal of Clinical Investigation.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication